SCI Abstract

search
+
Risk Factors Favoring Plaque Erosion
Risk Factors Favoring Plaque Erosion
Plaque erosion is the second leading cause of coronary thrombosis following plaque rupture and represents a key pathophysi...
“Anti-inflammatory Therapies in Atherosclerosis – Where are we going?”
“Anti-inflammatory Therapies in Atherosclerosis – Where are we going?”
Inflammation has been commonly known for the past decade as a part of the pathophysiology of atherosclerosis, along with l...
Inflammation in the Peri-ACS Period: Ready for Prime Time?
Inflammation in the Peri-ACS Period: Ready for Prime Time?
Inflammation has been demonstrated to negatively impact patients in the peri-ACS period. This narrative review outlines th...
Statin therapy in primary and secondary cardiovascular disease prevention
Statin therapy in primary and secondary cardiovascular disease prevention
Atherosclerotic cardiovascular disease (ASCVD) is one of the most common causes of death globally and the leading one in t...
The Use of Retinal Imaging Including Fundoscopy, OCT, and OCTA for Cardiovascular Risk Stratification and the Detection of Subclinical Atherosclerosis
The Use of Retinal Imaging Including Fundoscopy, OCT, and OCTA for Cardiovascular Risk Stratification and the Detection of Subclinical Atherosclerosis
Cardiovascular disease (CVD) is a leading cause of preventable morbidity and mortality globally, and retinal imaging modal...
Debate: Lipid-lowering Therapies and Diabetes Development
Debate: Lipid-lowering Therapies and Diabetes Development
This review explores the relationship between lipid-lowering therapies, particularly statins, and the risk of new-onset di...
From Genetic Findings to new Intestinal Molecular Targets in Lipid Metabolism
From Genetic Findings to new Intestinal Molecular Targets in Lipid Metabolism
While lipid-lowering therapies demonstrate efficacy, many patients still contend with significant residual risk of atheros...
Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk
Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk
Discuss the relationship between pregnancy complications and long-term atherosclerotic cardiovascular disease (ASCVD) risk...
Exposomic Determinants of Atherosclerosis: Recent Evidence
Exposomic Determinants of Atherosclerosis: Recent Evidence
The exposome refers to the total environmental exposures a person encounters throughout life, and its relationship with hu...
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
The purpose of this review is to provide an overview of the current status of lipid-lowering therapy utilization and lipid...
Leveraging Mobile Health and Wearable Technologies for the Prevention and Management of Atherosclerotic Cardiovascular Disease
Leveraging Mobile Health and Wearable Technologies for the Prevention and Management of Atherosclerotic Cardiovascular Disease
This review aims to assess the role of mobile health (mHealth) interventions and wearable technologies in the prevention a...
Sex-based Differences in Complications Following Percutaneous Coronary Interventions
Sex-based Differences in Complications Following Percutaneous Coronary Interventions
The role that sex plays in the incidence and outcomes of PCI related complications is not well understood. The purpose of ...
Quo Vadis after AEGIS: New Opportunities for Therapies Targeted at Reverse Cholesterol Transport?
Quo Vadis after AEGIS: New Opportunities for Therapies Targeted at Reverse Cholesterol Transport?
High-density lipoprotein (HDL) is integral to reverse cholesterol transport (RCT), a process considered to protect against...
Sex Differences in Cardiac Transplantation
Sex Differences in Cardiac Transplantation
The goal of this review was to summarize contemporary evidence surrounding sex differences in heart transplantation (HT). ...
Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?
Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?
The UK National Health Service (NHS) has recently announced a Newborn Genomes Programme (NGP) to identify infants with tre...
HDL as a Treatment Target: Should We Abandon This Idea?
HDL as a Treatment Target: Should We Abandon This Idea?
High-density lipoproteins (HDL) have long been regarded as an antiatherogenic lipoprotein species by virtue of their role ...
Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease
Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease
Characterize the risk of cardiovascular disease (CVD) in individuals with polycystic ovarian syndrome (PCOS). Review the p...
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management
To review current evidence, discuss key knowledge gaps and identify opportunities for development, validation and applicat...
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?
An evidence for lipid lowering therapy in heart failure is briefly summarized in this review. Heart failure therapy is bas...
Gene Regulatory Networks in Coronary Artery Disease
Gene Regulatory Networks in Coronary Artery Disease
Coronary artery disease is a complex disorder and the leading cause of mortality worldwide. As technologies for the genera...
Caregiver Influences on Eating Behaviors in Children: An Opportunity for Preventing Obesity
Caregiver Influences on Eating Behaviors in Children: An Opportunity for Preventing Obesity
This review seeks to define caregiver practices that impact childhood eating behaviors and identify ways to utilize these ...
Natural Sirtuin1 Activators and Atherosclerosis: an Overview
Natural Sirtuin1 Activators and Atherosclerosis: an Overview
The purpose of this review is to summarize the most recent findings investigating the impact of several natural sirtuin (S...
Emerging Preventive Strategies in Chronic Kidney Disease: Recent Evidence and Gaps in Knowledge
Emerging Preventive Strategies in Chronic Kidney Disease: Recent Evidence and Gaps in Knowledge
Chronic kidney disease (CKD) is increasingly prevalent worldwide and is associated with increased cardiovascular risk. New...
Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches
Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches
In this review, we sought to provide an overview of ML and focus on the contemporary applications of ML in cardiovascular ...
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
The purpose of this review is to critically discuss whether more aggressive lipid-lowering strategies are needed in patien...
Obesity and Dyslipidemia
Obesity and Dyslipidemia
This article sumarizes pathopysiological consequencies between obesity and dyslipidemia and aims to bring some practical a...
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress
To summarize selected late-breaking science on cardiovascular (CV) disease prevention presented at the 2023 European Socie...
Rap1 in the Context of PCSK9, Atherosclerosis, and Diabetes
Rap1 in the Context of PCSK9, Atherosclerosis, and Diabetes
The focus of this article is to highlight the importance of the small GTPase, Ras-associated protein 1 (Rap1), in proprote...
Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy
Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy
To discuss and review the technical considerations, fundamentals, and guideline-based indications for coronary artery calc...
The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations
The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations
Stroke is the second leading cause of death and disability-adjusted life years worldwide, and the global lifetime risk of ...
Load More
format_indent_increase